Ann: VLA initiates Clinical Trial of CAVATAK and PD-1 Combination, page-2

Good. About time. This is important clinically and from a transaction point of view.

Viralytics needed human drug combo trials running with both of the current main drugs. Now sorted.

If as expected, early results indicate either or both combos are more effective than the current marketed treatments ...
Well. Competitive tension is a good thing.

I just hope the board doesn't then hang on too long. The stage is set for a deal within 6 months. Don't make us wait!